New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 19, 2014
15:03 EDTARRY, FRXArray BioPharma hires new Chief Scientific Officer, VP of R&D
Array BioPharma (ARRY) announced the appointments of Nicholas Saccomano, Ph.D., as Chief Scientific Officer and Robert Winkler, M.D., as VP of Clinical Research and Development. Saccomano most recently served as Chief Technology Officer at SomaLogic and as Chief Scientific Officer at Bend Research. Winkler most recently served as VP of Global Clinical Development and Operations at Aptalis Pharma, which was recently acquired by Forest Labs (FRX).
News For ARRY;FRX From The Last 14 Days
Check below for free stories on ARRY;FRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 12, 2014
13:48 EDTARRYArray names Sandor Chief Medical Officer to replace Needle
Subscribe for More Information
September 11, 2014
18:15 EDTARRYArray BioPharma names Victor Sandor as Chief Medical Officer
Array BioPharma (ARRY) announced the appointment of Victor Sandor, M.D., as Chief Medical Officer. Prior to joining Array, Sandor was senior VP for Global Clinical Development at Incyte Corporation (INCY). Sandor will replace Array's prior Chief Medical Officer, Michael Needle, M.D., who is leaving the company to pursue other opportunities.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use